NRXPW
Price:
$0.0551
Market Cap:
$40.97M
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
Industry
Biotechnology
IPO Date
2017-12-01
Stock Exchange
NASDAQ
Ticker
NRXPW
According to NRx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 34.13M. This represents a change of -30.73% compared to the average of 49.27M of the last 4 quarters.
The mean historical Enterprise Value of NRx Pharmaceuticals, Inc. over the last ten years is 421.34M. The current 34.13M Enterprise Value has changed 710.05% with respect to the historical average. Over the past ten years (40 quarters), NRXPW's Enterprise Value was at its highest in in the September 2021 quarter at 5.04B. The Enterprise Value was at its lowest in in the September 2017 quarter at 17.53K.
Average
421.34M
Median
89.36M
Minimum
28.27M
Maximum
2.22B
Discovering the peaks and valleys of NRx Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.57%
Maximum Annual Enterprise Value = 2.22B
Minimum Annual Increase = -94.53%
Minimum Annual Enterprise Value = 28.27M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 28.27M | -28.27% |
| 2023 | 39.42M | -94.53% |
| 2022 | 720.48M | -67.48% |
| 2021 | 2.22B | 1.57% |
| 2020 | 132.30M | 136.73% |
| 2019 | 55.89M | -39.06% |
| 2018 | 91.71M | 5.40% |
The current Enterprise Value of NRx Pharmaceuticals, Inc. (NRXPW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
262.72M
5-year avg
627.21M
10-year avg
421.34M
NRx Pharmaceuticals, Inc.’s Enterprise Value is less than CervoMed Inc. (62.00M), less than Gain Therapeutics, Inc. (97.31M), less than vTv Therapeutics Inc. (68.40M), greater than Adicet Bio, Inc. (21.75M), greater than MiNK Therapeutics, Inc. (-14226806744.00), greater than Adagene Inc. (12.64M), greater than IO Biotech, Inc. (18.60M), greater than Werewolf Therapeutics, Inc. (-23633896.00), less than Revolution Medicines, Inc. (15.17B), less than Lite Strategy, Inc. (42.49M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 62.00M | $70.32M | |
| 97.31M | $103.78M | |
| 68.40M | $94.25M | |
| 21.75M | $41.11M | |
| -14226806744.00 | $54.41M | |
| 12.64M | $68.62M | |
| 18.60M | $47.81M | |
| -23633896.00 | $33.33M | |
| 15.17B | $15.23B | |
| 42.49M | $52.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NRx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NRx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is NRx Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for NRx Pharmaceuticals, Inc. (NRXPW)?
What is the 3-year average Enterprise Value for NRx Pharmaceuticals, Inc. (NRXPW)?
What is the 5-year average Enterprise Value for NRx Pharmaceuticals, Inc. (NRXPW)?
How does the current Enterprise Value for NRx Pharmaceuticals, Inc. (NRXPW) compare to its historical average?